Rena Therapeutics Inc. was established in January 2015 with the aim of accelerating the practical application of the groundbreaking nucleic acid pharmaceutical technology known as Hetero Double-Stranded Nucleic Acid Technology. In February of the same year, we were granted the title of university-launched venture by Tokyo Medical and Dental University.
Hetero Double-Stranded Nucleic Acid Technology is Japan’s third novel nucleic acid pharmaceutical with high universality, applicability, and scalability. It enabled, for the first time, gene control in organs other than the liver via systemic administration, which had been the major obstacle in the clinical application of nucleic acid pharmaceuticals, by conjugating ligands tailored to the target.
The advantage of nucleic acid pharmaceuticals lies in the ability to design drug compounds based on the sequence information of the target genes once the mechanisms related to the genes targeted for treatment are elucidated. In the future, personalized medicine will be possible by designing drugs tailored to the genetic sequences of individual patients.
Our company aims to deliver therapeutic drugs to patients as soon as possible by providing solutions tailored to the needs of our customers using Hetero Double-Stranded Nucleic Acid and various ligands and contributing to the creation of new nucleic acid pharmaceuticals.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 大手町1-9-2, 大手町フィナンシャルシティ グランキューブ３階,japan
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- 千代田区, 東京都
Rena Therapeutics Inc. / レナセラピューティクス株式会社 Questions
Rena Therapeutics Inc. / レナセラピューティクス株式会社's website is https://www.renatherapeutics.com/
Rena Therapeutics Inc. / レナセラピューティクス株式会社's LinkedIn profile is https://jp.linkedin.com/company/renatherapeutics
Rena Therapeutics Inc. / レナセラピューティクス株式会社 has
10 employees.
View email and phone details for 10
employees at Rena Therapeutics Inc. / レナセラピューティクス株式会社.
Rena Therapeutics Inc. / レナセラピューティクス株式会社's industry is
Biotechnology Research
Rena Therapeutics Inc. / レナセラピューティクス株式会社's top competitors are
Sansho Co., Ltd.,
Fujirebio,
Awakapp Inc.,
Mirai Genomics,
Dove Biotech Co., Ltd.,
Actmed（アクトメッド株式会社）,
Therawin,
シップスバイオサイエンス株式会社,
Hummingbird Bioscience,
Institute Of Bioinformatics - University Of Georgia.
Rena Therapeutics Inc. / レナセラピューティクス株式会社's categories are Biotechnology Research
Rena Therapeutics Inc. / レナセラピューティクス株式会社's founding year is 2015
